USD
+$0.00
(+0.00%
)At Close (As of Oct 13, 2025)
$1.37B
Market Cap
-
P/E Ratio
-3.25
EPS
$55.63
52 Week High
$23.91
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $263M |
Total Revenue | $656M |
Cost Of Revenue | $393M |
Costof Goods And Services Sold | $393M |
Operating Income | -$201M |
Selling General And Administrative | $303M |
Research And Development | $34M |
Operating Expenses | $464M |
Investment Income Net | - |
Net Interest Income | $33M |
Interest Income | $33M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $91M |
Income Before Tax | -$167M |
Income Tax Expense | -$3.2M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$164M |
Comprehensive Income Net Of Tax | - |
Ebit | -$73M |
Ebitda | $18M |
Net Income | -$164M |
Field | Value (USD) |
---|---|
Total Assets | $2.1B |
Total Current Assets | $833M |
Cash And Cash Equivalents At Carrying Value | $311M |
Cash And Short Term Investments | $311M |
Inventory | $115M |
Current Net Receivables | $173M |
Total Non Current Assets | $1.3B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $248M |
Intangible Assets Excluding Goodwill | $248M |
Goodwill | $691M |
Investments | - |
Long Term Investments | $49M |
Short Term Investments | $151M |
Other Current Assets | $83M |
Other Non Current Assets | - |
Total Liabilities | $331M |
Total Current Liabilities | $205M |
Current Accounts Payable | $44M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $11M |
Total Non Current Liabilities | $126M |
Capital Lease Obligations | $59M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $71M |
Other Current Liabilities | $105M |
Other Non Current Liabilities | $13M |
Total Shareholder Equity | $1.8B |
Treasury Stock | - |
Retained Earnings | $1.5B |
Common Stock | $590K |
Common Stock Shares Outstanding | $53M |
Field | Value (USD) |
---|---|
Operating Cashflow | $50M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $91M |
Capital Expenditures | $37M |
Change In Receivables | - |
Change In Inventory | $3.3M |
Profit Loss | - |
Cashflow From Investment | $225M |
Cashflow From Financing | -$659M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $0 |
Dividend Payout Common Stock | $0 |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$662M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$164M |
Field | Value (USD) |
---|---|
Gross Profit | $263M |
Total Revenue | $656M |
Cost Of Revenue | $393M |
Costof Goods And Services Sold | $393M |
Operating Income | -$201M |
Selling General And Administrative | $303M |
Research And Development | $34M |
Operating Expenses | $464M |
Investment Income Net | - |
Net Interest Income | $33M |
Interest Income | $33M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $91M |
Income Before Tax | -$167M |
Income Tax Expense | -$3.2M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$164M |
Comprehensive Income Net Of Tax | - |
Ebit | -$73M |
Ebitda | $18M |
Net Income | -$164M |
Field | Value |
---|---|
Ex Dividend Date | 2021-12-02 |
Declaration Date | None |
Record Date | None |
Payment Date | None |
Amount | 0.1 |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
None